Laboratorium fistulae

Productum

Milbemycin oxime 129496-10-2 Anti-parasitica Antibiotica

Description:

Product nomen:Milbemycin oxime
Synonyma:MilbeMycin oxiMe
CAS No.:129496-10-2
Qualitas:USP42
Formulae hypotheticae:2C32H45NO7.2C31H43NO7
Pondus hypotheticum:2194.78


Product Detail

Product Tags

Mercedem:T/T, L/C
Product Origin:China
Shipping Portus:Beijing/Shanghai/Hangzhou
Order (MOQ);1kg
Tempus ducere:III opus diebus
Facultas productio;30kg / mensis
Repono conditione:Condita in loco frigido, sicco, cella temperie.
Sarcina materia:utrem
Sarcina amplitudo:1kg/utrem
Salus notitia:Non periculosum bonis

Milbemycin oxime

Introductio

Est macrolide anticorpus parasitus internum et externum medicamentum, et est oxime derivatio milbemycini A3 et A4.

Milbemycin oxime, medicamentum veterinarium e grege milbemycinum, latum spectrum antiparasiticum adhibitum est.Activa est contra lumbricos (anthelminticos) et minuta.

Specification (USP42)

Item

Specification

Aspectus Album vel off-pulveris alba
Lepidium sativum Infrared spectroscopium
Retentione tempora scopulorum maioris Sample solutionis respondent illis solutioni Vexillifero, prout habetur in Assay.
Reliqua ignitio ≤0.5%
immunditiae organicae 11'-Desmethylmibemycin A4 oxime ≤0.7%
(20'R) -Hydroxymilbemycin A4 keto form ≤0.5%
Milbemycin A4 keto formare ≤0.7%
Milbemycin D-oxime ≤3.0%
Quaelibet alia individua immunditia ≤0.5%
Totalis immunditias ≤3.5%
Aquae determinationem ≤3.0%
RELICTUM menstrua Ethanol ≤5000ppm
N-Heptane ≤5000ppm
Acetone ≤5000ppm
Dichloromethane ≤600ppm
Chloroform ≤60ppm
Microbial terminus Totalis bacteria aerobic ≤500cfu/g*
Totalis combined fermentis et fingit ≤100cfu/g*
Escherichia coli Abest/g
Assay Milbemycin Oxime (A3+A4): 95.0%~ 101.0%, calculata anhydroa fundamento
Ratio A4 / (A3+A4) ≥0.80
Ratio A3 / (A3+A4) ≤0.20%

  • Previous:
  • Deinde: